Prosecution Insights
Last updated: August 17, 2026

Examiner: KELLY, ROBERT M

Tech Center 1600 • Art Units: 1631 1633 1638 1651 1654 1656 1657

This examiner grants 74% of resolved cases

Performance Statistics

73.8%
Allow Rate
+13.8% vs TC avg
963
Total Applications
+24.8%
Interview Lift
1055
Avg Prosecution Days
Based on 927 resolved cases, 2023–2026

Rejection Statute Breakdown

4.5%
§101 Eligibility
15.9%
§102 Novelty
18.9%
§103 Obviousness
43.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18010674 METHODS OF IDENTIFYING AND CHARACTERIZING ANELLOVIRUSES AND USES THEREOF Final Rejection FLAGSHIP PIONEERING INNOVATIONS V, INC.
18573858 METHODS AND COMPOSITIONS FOR REMOTE CONTROL OF T CELL THERAPIES BY THERMAL TARGETING Non-Final OA GEORGIA TECH RESEARCH CORPORATION
18342642 METHODS OF TREATING LYSOSOMAL DISORDERS Non-Final OA The Regents of the University of California
18587729 METHODS FOR ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION Non-Final OA The Board of Trustees of the Leland Stanford Junior University
18031413 Gelatin Microparticles Containing Nutrients for Cell Culture Therein, Preparation Method Therefor, and Use Thereof Non-Final OA CJ CHEILJEDANG CORPORATION
18325332 Systemic Delivery of Polypeptides Non-Final OA The General Hospital Corporation

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month